Regulatory Updates
🇺🇸 FDA Page 20FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 229–240 of 382 articles
Big Pharma's M&A Spree and the March IPO Drought: An Analysis
Pharma M&A Set to Boom in 2026: Market Analysis
Big Pharma's Race for Biotech Assets Amid $170 Billion Patent Cliff
Life Sciences Dealmaking Gains Momentum Amid Strategic Pressures
Research Progress and Development Strategies of Antibody-Oligonucleotide Conjugates
FDA PreCheck Pilot Program Launches: A New Era for Clinical Trials
FDA Approves Durvalumab and BCG for High-Risk NMIBC
FDA Alert: Infectious Diseases Drug News Roundup 2026
Leap Therapeutics Stock Edges Higher After Recent Data
Seven Biopharma Trends to Watch in 2026: Clinical Trials Insights
Experimental IgG4-RD Drug Submission to FDA After Successful Trial
US FDA Extends Decision Date for Camizestrant Filing